ArticleiGIE : innovation, investigation and insights2023
Efficacy of peroral endoscopic myotomy for the treatment of functional esophagogastric junction outflow obstruction.
Article in iGIE : innovation, investigation and insights, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Idiopathic or functional esophagogastric junction outflow obstruction (EGJOO) is characterized by preserved peristalsis and an elevated integrated relaxation pressure of the lower esophageal sphincter (LES) without mechanical obstruction. Data on efficacy of peroral endoscopic myotomy (POEM) in EGJOO are limited. Prior studies included heterogeneous patients and those with prior LES interventions such as pneumatic dilation and Heller myotomy. The aim of this study was to determine outcomes of POEM in EGJOO without prior pneumatic dilation or Heller myotomy. Methods: We reviewed medical records of patients who had POEM for EGJOO between 2014 and 2022 at our institution. The primary outcome was clinical success, defined as a reduction in Eckardt score to ≤3. Secondary outcomes were technical success, adverse events, reduction in LES pressure on high-resolution esophageal manometry (HREM), improvement in timed barium esophagram (TBE), and esophageal pH study findings. Results: Seventeen patients (9 female subjects; mean age 57.8 ± 14.4 years) met study criteria. POEM was technically successful in all patients, with no significant adverse events. Clinical success was achieved in 94.1% (16 of 17) of patients. There was a significant improvement in barium column height on TBE at 1 and 5 minutes (9.5 ± 6.2 cm vs 2.6 ± 2.6 cm [ Conclusions: POEM seems to provide high clinical success along with improvement in TBE and HREM in EGJOO; however, GERD is very common after POEM.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.